EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Hyperglycemia‐Induced Microglial CTSS Disrupts Blood‐Retinal Barrier Integrity via PAR2 ‐Dependent Downregulation of Endothelial MFSD2A

Chengye Xu, Hongxue Li, Qian Xu iD, Kangqi Zhao, Yangwen Chen, Yan Wang, Wei Zou, Binglin Kuang, Hongyu Kuang iD

CNS Neuroscience & Therapeutics · 2026-10 · 32 (10)

DOI: 10.1002/cns.71187 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 28.09.2026. Verfasst von Chengye Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, China. Hauptthemen laut MEDLINE: Microglia, Blood-Retinal Barrier, Endothelial Cells, Hyperglycemia. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Diabetic retinopathy (DR), a leading cause of blindness in diabetes, involves dysregulated neuroimmune crosstalk. While microglial activation and endothelial dysfunction are established in DR, the molecular mechanisms linking innate immunity to blood‐retinal barrier (BRB) breakdown remain elusive.

Methods

We combined single‐cell RNA sequencing (scRNA‐seq) of diabetic mouse retinas with in vivo models, retinal endothelial MFSD2A overexpression, and microglial Cathepsin S (CTSS) knockdown via adeno‐associated virus (AAV). Human retinal microvascular endothelial cells (HRMECs) and human microglial cells (HMC3) were subjected to high‐glucose conditions combined with in vitro systems (transwell co‐cultures, holographic 3D tomography). Mechanistic studies employed siRNA knockdown, plasmid overexpression, exogenous CTSS supplementation, and transcytosis assays. Results scRNA‐seq revealed diabetes‐induced CTSS upregulation in retinal microglia ( p = 0.0031) and MFSD2A downregulation in endothelial cells ( p = 0.01). Microglial CTSS promoted M1 polarization ( p < 0.001) and pro‐inflammatory cytokine secretion (IL‐1β and TNF‐α, p < 0.05), while Ctss knockdown attenuated these effects ( p < 0.05). CTSS activated endothelial PAR2, suppressing endothelial MFSD2A and enhancing caveolin‐1‐mediated transcytosis. Endothelial MFSD2A overexpression reduced vascular permeability independently of tight junction modulation (ZO‐1, Occludin, Claudin‐5, p > 0.05). Microglia‐endothelial crosstalk was disrupted in diabetes, with ultrastructural alterations (cytoplasmic shrinkage, microglial amoeboid transformation) promoting cytotoxic interactions and exacerbate vascular endothelial damage.

Conclusions

Hyperglycemia induces retinal microglial activation and CTSS upregulation, disrupting microglia‐endothelial crosstalk via the PAR2 pathway, suppressing endothelial MFSD2A expression, enhancing transcytosis, compromising iBRB integrity, and accelerating DR progression. Therapeutic strategies targeting microglial CTSS or endothelial MFSD2A represent promising avenues for preserving vision in diabetic patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicrogliaBlood-Retinal BarrierEndothelial CellsHyperglycemiaReceptor, PAR-2AnimalsMiceHumansDown-RegulationMice, Inbred C57BLDiabetic RetinopathyMaleSymporters

Stichwörter der Autor:innen

Cathepsin Sdiabetic retinopathyendothelial cellsmajor facilitator superfamily domain‐containing protein 2amicroglia

Substanzen

Mfsd2a protein, mouseReceptor, PAR-2Symporters

Autor:innen und Institutionen

  • The Department of Endocrinology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.
  • Acupuncture and Moxibustion Department III, The First Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine, Harbin, China.

ORCID-Profile: Qian Xu, Hongyu Kuang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xu, C., Li, H., Xu, Q., Zhao, K., Chen, Y., Wang, Y., Zou, W., Kuang, B., & Kuang, H. (2026). Hyperglycemia‐Induced Microglial CTSS Disrupts Blood‐Retinal Barrier Integrity via PAR2 ‐Dependent Downregulation of Endothelial MFSD2A. CNS Neuroscience & Therapeutics, 32(10). https://doi.org/10.1002/cns.71187

Vancouver

Xu C, Li H, Xu Q, Zhao K, Chen Y, Wang Y, et al. Hyperglycemia‐Induced Microglial CTSS Disrupts Blood‐Retinal Barrier Integrity via PAR2 ‐Dependent Downregulation of Endothelial MFSD2A. CNS Neuroscience & Therapeutics. 2026;32(10). doi:10.1002/cns.71187

BibTeX
@article{Xu2026,
  author = {Xu, Chengye and Li, Hongxue and Xu, Qian and Zhao, Kangqi and Chen, Yangwen and Wang, Yan and Zou, Wei and Kuang, Binglin and Kuang, Hongyu},
  title = {Hyperglycemia‐Induced Microglial CTSS Disrupts Blood‐Retinal Barrier Integrity via PAR2 ‐Dependent Downregulation of Endothelial MFSD2A},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2026},
  volume = {32},
  number = {10},
  doi = {10.1002/cns.71187}
}
Kostenlos starten →